Abstract
Small molecules that perturb developmental signaling pathways can have devastating effects on embryonic patterning, as evidenced by the chemically induced onset of cyclopic lambs and children with severely shortened limbs during the 1950s. Recent studies, however, have revealed critical roles for these pathways in human disorders and diseases, spurring the re-examination of these compounds as new targeted therapies. In this tutorial review, we describe four case studies of teratogenic compounds, including inhibitors of the Hedgehog (Hh), Wnt, and bone morphogenetic protein (BMP) pathways. We discuss how these teratogens were discovered, their mechanisms of action, their utility as molecular probes, and their potential as therapeutic agents. We also consider current challenges in the field and possible directions for future research.
This journal is © The Royal Society of Chemistry 2011
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Body Patterning / drug effects
-
Bone Morphogenetic Proteins / antagonists & inhibitors
-
Growth and Development / physiology*
-
Hedgehog Proteins / antagonists & inhibitors
-
Heterocyclic Compounds, 3-Ring / chemistry
-
Heterocyclic Compounds, 3-Ring / pharmacology
-
Humans
-
Pyrazoles / chemistry
-
Pyrazoles / pharmacology
-
Pyrimidines / chemistry
-
Pyrimidines / pharmacology
-
Signal Transduction / drug effects*
-
Small Molecule Libraries
-
Teratogens / chemistry*
-
Teratogens / pharmacology*
-
Thalidomide / adverse effects
-
Thalidomide / therapeutic use
-
Veratrum Alkaloids / chemistry
-
Veratrum Alkaloids / pharmacology
-
Wnt Proteins / antagonists & inhibitors
Substances
-
Bone Morphogenetic Proteins
-
Hedgehog Proteins
-
Heterocyclic Compounds, 3-Ring
-
Pyrazoles
-
Pyrimidines
-
Small Molecule Libraries
-
Teratogens
-
Veratrum Alkaloids
-
Wnt Proteins
-
XAV939
-
dorsomorphin
-
Thalidomide
-
cyclopamine